查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1600094

醫療保健市場開拓受託製造廠商市場：按服務、最終用戶分類 - 2025-2030 年全球預測

Healthcare Contract Development & Manufacturing Organization Market by Services, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年醫療保健市場價值為3063.8億美元，預計到2024年將達到3319.9億美元，複合年成長率為8.84%，到2030年將達到5543.9億美元。

醫療保健合約開發和受託製造廠商(CDMO) 市場包括為製藥和生物技術公司提供的各種服務，包括藥物開發、臨床試驗管理和商業規模製造。由於製藥公司在不需要大量內部投資的情況下降低成本、縮短時間和獲得專業知識的壓力越來越大，對此類服務的需求正在增加。 CDMO 在藥物研發過程中發揮關鍵作用，提供靈活的解決方案，促進創新、監管合規和治療進步。最終用途範圍廣泛，從小分子藥物到生技藥品，涉及腫瘤學、神經病學和感染疾病等領域。

主要市場統計
基準年[2023] 3063.8億美元
預測年份 [2024] 3319.9億美元
預測年份 [2030] 5543.9億美元
複合年成長率（%） 8.84%

根據市場洞察，CDMO產業受到生技藥品需求增加、複雜技術平台需求以及嚴格監管要求等因素的顯著影響。生物相似藥以及細胞和基因療法的最新進展提供了有希望的成長機會。公司可以利用這些機會，加強先進治療方法的能力並擴大服務範圍，以適應個人化醫療的趨勢。然而，許多限制仍然存在，包括嚴格的監管監督、供應鏈複雜性和品質保證挑戰。最迫切的挑戰之一是維持生產擴充性的高標準，這需要對品管系統和基礎設施進行大量投資。

需要創新的領域包括將人工智慧和機器學習整合用於藥物開發中的預測分析、提高製造效率的自動化以及最大限度地減少環境影響的永續生產實踐等。持續的製造流程研究有可能透過降低成本和提高品質來進一步革新生產。市場本質上是競爭性的，CDMO 必須靈活應對快速變化的藥物開發環境。透過專注於策略夥伴關係關係、投資最尖端科技並確保遵守全球監管標準，Masu 可以確保持續成長並在這個充滿活力的市場中保持競爭力。

市場動態：揭示快速發展的醫療保健市場的關鍵市場洞察

供需的動態交互作用正在改變醫療保健市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 由於慢性病的增加對生技藥品的需求增加
    • 依賴先進製造能力的複雜醫療保健治療的增加
  • 市場限制因素
    • 醫療 CDMO 服務營運成本高
  • 市場機會
    • 採用創新技術提升 CDMO 服務效率
    • 與生技公司策略聯盟提供CDMO服務
  • 市場挑戰
    • CDMO 服務的嚴格監管審查

波特五力：駕馭醫療保健市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解醫療保健市場的外部影響

外部宏觀環境因素在塑造醫療保健市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解醫療保健市場的競爭狀況

醫療保健市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示自己的競爭定位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣醫療保健市場供應商的績效評估

FPNV 定位矩陣是評估醫療保健市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議繪製醫療保健市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，醫療保健市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 由於慢性病的增加，對生物製藥的需求不斷增加
      • 依賴先進製造能力的複雜醫療程序的增加
    • 抑制因素
      • 醫療CDMO服務營運成本高
    • 機會
      • 引進創新技術提高CDMO服務效率
      • 與生技公司策略聯盟提供CDMO服務
    • 任務
      • CDMO服務的嚴格監管
  • 市場區隔分析
    • 服務：增加最終劑量製劑的使用，重點在於特種藥物和生技藥品
    • 最終用戶：大型製藥公司擴大採用 CDMO 服務來支援大規模臨床和商業生產
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 醫療保健市場開拓受託製造廠商市場：依服務分類

  • 合約開發
    • 高分子
      • 細胞株開發
      • 製程開發
    • 小分子
      • 臨床
      • 第一階段
      • 第二階段
      • 第三階段
      • 第四階段
      • 化驗服務
      • 分析服務
      • 生物分析服務
      • 臨床前
      • 生物分析和 DMPK 研究
      • 其他臨床前服務
      • 毒性試驗
  • 契約製造
    • 最終劑量配方
    • 高效API
    • 高分子
    • 醫療設備
    • 小分子

第7章 醫療保健市場開拓受託製造廠商市場：依最終使用者分類

  • 大型製藥公司
  • 學名藥公司
  • 中小型製藥企業

第8章 北美和南美醫療保健市場開拓受託製造廠商市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太地區醫療保健市場開拓受託製造廠商市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲、中東和非洲醫療保健市場開拓受託製造廠商市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • FUJIFILM投資 12 億美元擴建霍利斯普林斯的生技工廠
    • FUJIREBIO Holdings 與 Agappe Diagnostics 簽署 CDMO 合作夥伴關係，以本地生產化學冷光解決方案
    • Enzen Biosciences 在美國開設首個製造地，以擴大生技夥伴關係和市場佔有率
  • 戰略分析和建議

公司名單

  • Baxter International, Inc.
  • Boehringer Ingelheim International GmbH
  • Cambrex Corporation
  • Catalent Inc.
  • Charles River Laboratories International, Inc.
  • Corden Pharma International GmbH
  • Curia Global, Inc.
  • Eurofins Scientific SE
  • EVER company group
  • Evonik Industries AG
  • FUJIFILM Diosynth Biotechnologies
  • Jabil, Inc.
  • Laboratory Corporation of America Holdings
  • Lonza Group AG
  • MedPharm Ltd.
  • Merck KGaA
  • Piramal Group
  • Porton Pharma Solutions Ltd
  • Recipharm AB
  • Samsung Biologics
  • Sanmina Corporation
  • Siegfried Holding AG
  • Siegfried-Group
  • Thermo Fisher Scientific, Inc.
  • WuXi AppTec
Product Code: MRR-B812DD5799E8

The Healthcare Contract Development & Manufacturing Organization Market was valued at USD 306.38 billion in 2023, expected to reach USD 331.99 billion in 2024, and is projected to grow at a CAGR of 8.84%, to USD 554.39 billion by 2030.

The scope of the healthcare contract development and manufacturing organization (CDMO) market encompasses a variety of services tailored towards pharmaceutical and biotechnology companies, including drug development, clinical trial management, and commercial-scale production. The growing necessity for these services continues to be driven by increasing pressure on pharmaceutical companies to reduce costs, accelerate timelines, and access specialized expertise without extensive in-house investment. CDMOs play a crucial role in drug research and development processes, offering flexible solutions that facilitate innovation, regulatory compliance, and therapeutic advancement. The end-use scope is vast, covering everything from small molecule drugs to biologics, and extending to sectors including oncology, neurology, and infectious diseases.

KEY MARKET STATISTICS
Base Year [2023] USD 306.38 billion
Estimated Year [2024] USD 331.99 billion
Forecast Year [2030] USD 554.39 billion
CAGR (%) 8.84%

Market insights reveal that the CDMO industry is significantly influenced by factors such as the rise in demand for biologics, the need for sophisticated technology platforms, and stringent regulatory requirements. Recent advancements in biosimilars and cell and gene therapies present promising opportunities for growth. Companies can capitalize on these opportunities by enhancing capabilities in advanced therapeutic modalities and expanding service offerings to cater to personalized medicine trends. Nonetheless, limitations such as high regulatory scrutiny, supply chain complexities, and quality assurance challenges remain prevalent. One of the most pressing challenges is maintaining high standards amid production scalability, which necessitates substantial investment in quality management systems and infrastructure.

Areas ripe for innovation include the integration of AI and machine learning for predictive analytics in drug development, automation for improved efficiency in manufacturing, and sustainable production practices to minimize environmental impact. Research into continuous manufacturing processes could further revolutionize production by reducing costs and improving quality. The market is intrinsically competitive, requiring CDMOs to be agile and adaptive to rapidly changing drug development landscapes. By focusing on strategic partnerships, investing in cutting-edge technologies, and ensuring compliance with global regulatory standards, CDMOs can secure sustained growth and maintain a competitive edge in this dynamic market.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Healthcare Contract Development & Manufacturing Organization Market

The Healthcare Contract Development & Manufacturing Organization Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing demand for biologics with increasing prevalence of chronic diseases
    • Rising complex healthcare treatments with the reliance on advanced manufacturing capabilities
  • Market Restraints
    • High operational costs of healthcare CDMO services
  • Market Opportunities
    • Adoption of innovative technologies that enhance the efficiency of CDMO services
    • Strategic partnerships with biotech firms for CDMO services
  • Market Challenges
    • Stringent regulatory scrutiny for CDMO services

Porter's Five Forces: A Strategic Tool for Navigating the Healthcare Contract Development & Manufacturing Organization Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Healthcare Contract Development & Manufacturing Organization Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Healthcare Contract Development & Manufacturing Organization Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Healthcare Contract Development & Manufacturing Organization Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Healthcare Contract Development & Manufacturing Organization Market

A detailed market share analysis in the Healthcare Contract Development & Manufacturing Organization Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Healthcare Contract Development & Manufacturing Organization Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Healthcare Contract Development & Manufacturing Organization Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Healthcare Contract Development & Manufacturing Organization Market

A strategic analysis of the Healthcare Contract Development & Manufacturing Organization Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Healthcare Contract Development & Manufacturing Organization Market, highlighting leading vendors and their innovative profiles. These include Baxter International, Inc., Boehringer Ingelheim International GmbH, Cambrex Corporation, Catalent Inc., Charles River Laboratories International, Inc., Corden Pharma International GmbH, Curia Global, Inc., Eurofins Scientific SE, EVER company group, Evonik Industries AG, FUJIFILM Diosynth Biotechnologies, Jabil, Inc., Laboratory Corporation of America Holdings, Lonza Group AG, MedPharm Ltd., Merck KGaA, Piramal Group, Porton Pharma Solutions Ltd, Recipharm AB, Samsung Biologics, Sanmina Corporation, Siegfried Holding AG, Siegfried-Group, Thermo Fisher Scientific, Inc., and WuXi AppTec.

Market Segmentation & Coverage

This research report categorizes the Healthcare Contract Development & Manufacturing Organization Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Services, market is studied across Contract development and Contract manufacturing. The Contract development is further studied across Large Molecule and Small Molecule. The Large Molecule is further studied across Cell Line development and Process Development. The Small Molecule is further studied across Clinical, Laboratory Services, and Preclinical. The Clinical is further studied across Phase I, Phase II, Phase III, and Phase IV. The Laboratory Services is further studied across Analytical Services and Bioanalytical Services. The Preclinical is further studied across Bioanalysis and DMPK studies, Other Preclinical Services, and Toxicology Testing. The Contract manufacturing is further studied across Finished Dose Formulations, High Potency API, Large Molecule, Medical Devices, and Small Molecule.
  • Based on End-User, market is studied across Big Pharmaceutical Companies, Generic Pharmaceutical Companies, and Small & Medium-Sized Pharmaceutical Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing demand for biologics with increasing prevalence of chronic diseases
      • 5.1.1.2. Rising complex healthcare treatments with the reliance on advanced manufacturing capabilities
    • 5.1.2. Restraints
      • 5.1.2.1. High operational costs of healthcare CDMO services
    • 5.1.3. Opportunities
      • 5.1.3.1. Adoption of innovative technologies that enhance the efficiency of CDMO services
      • 5.1.3.2. Strategic partnerships with biotech firms for CDMO services
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulatory scrutiny for CDMO services
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Services: Growing usage of finished dose formulations with the focus on specialty medicine and biologics
    • 5.2.2. End-User: Rising adoption of CDMO services by big pharmaceutical companies to support large-scale clinical and commercial manufacturing
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Healthcare Contract Development & Manufacturing Organization Market, by Services

  • 6.1. Introduction
  • 6.2. Contract development
    • 6.2.1. Large Molecule
      • 6.2.1.1. Cell Line development
      • 6.2.1.2. Process Development
    • 6.2.2. Small Molecule
      • 6.2.2.1. Clinical
      • 6.2.2.1.1. Phase I
      • 6.2.2.1.2. Phase II
      • 6.2.2.1.3. Phase III
      • 6.2.2.1.4. Phase IV
      • 6.2.2.2. Laboratory Services
      • 6.2.2.2.1. Analytical Services
      • 6.2.2.2.2. Bioanalytical Services
      • 6.2.2.3. Preclinical
      • 6.2.2.3.1. Bioanalysis and DMPK studies
      • 6.2.2.3.2. Other Preclinical Services
      • 6.2.2.3.3. Toxicology Testing
  • 6.3. Contract manufacturing
    • 6.3.1. Finished Dose Formulations
    • 6.3.2. High Potency API
    • 6.3.3. Large Molecule
    • 6.3.4. Medical Devices
    • 6.3.5. Small Molecule

7. Healthcare Contract Development & Manufacturing Organization Market, by End-User

  • 7.1. Introduction
  • 7.2. Big Pharmaceutical Companies
  • 7.3. Generic Pharmaceutical Companies
  • 7.4. Small & Medium-Sized Pharmaceutical Companies

8. Americas Healthcare Contract Development & Manufacturing Organization Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Healthcare Contract Development & Manufacturing Organization Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Healthcare Contract Development & Manufacturing Organization Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
    • 11.3.1. FUJIFILM Corporation Invests USD 1.2 Billion to Expand Biotech Facility in Holly Springs
    • 11.3.2. Fujirebio Holdings and Agappe Diagnostics Form CDMO Partnership for Local Chemiluminescence Solution Production
    • 11.3.3. Enzene Biosciences Establishes First U.S. Manufacturing Site to Boost Biotech Partnerships and Market Presence
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Baxter International, Inc.
  • 2. Boehringer Ingelheim International GmbH
  • 3. Cambrex Corporation
  • 4. Catalent Inc.
  • 5. Charles River Laboratories International, Inc.
  • 6. Corden Pharma International GmbH
  • 7. Curia Global, Inc.
  • 8. Eurofins Scientific SE
  • 9. EVER company group
  • 10. Evonik Industries AG
  • 11. FUJIFILM Diosynth Biotechnologies
  • 12. Jabil, Inc.
  • 13. Laboratory Corporation of America Holdings
  • 14. Lonza Group AG
  • 15. MedPharm Ltd.
  • 16. Merck KGaA
  • 17. Piramal Group
  • 18. Porton Pharma Solutions Ltd
  • 19. Recipharm AB
  • 20. Samsung Biologics
  • 21. Sanmina Corporation
  • 22. Siegfried Holding AG
  • 23. Siegfried-Group
  • 24. Thermo Fisher Scientific, Inc.
  • 25. WuXi AppTec

LIST OF FIGURES

  • FIGURE 1. HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET RESEARCH PROCESS
  • FIGURE 2. HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET DYNAMICS
  • TABLE 7. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LARGE MOLECULE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CELL LINE DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PROCESS DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LARGE MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL MOLECULE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PHASE I, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PHASE II, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PHASE III, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PHASE IV, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LABORATORY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY ANALYTICAL SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY BIOANALYTICAL SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRECLINICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY BIOANALYSIS AND DMPK STUDIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY OTHER PRECLINICAL SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY TOXICOLOGY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRECLINICAL, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY FINISHED DOSE FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY HIGH POTENCY API, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LARGE MOLECULE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY MEDICAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL MOLECULE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY BIG PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY GENERIC PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL & MEDIUM-SIZED PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LARGE MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRECLINICAL, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. AMERICAS HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 53. ARGENTINA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LARGE MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 55. ARGENTINA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 56. ARGENTINA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 57. ARGENTINA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 58. ARGENTINA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRECLINICAL, 2018-2030 (USD MILLION)
  • TABLE 59. ARGENTINA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 60. ARGENTINA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. BRAZIL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 62. BRAZIL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 63. BRAZIL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LARGE MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 64. BRAZIL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 65. BRAZIL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 66. BRAZIL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 67. BRAZIL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRECLINICAL, 2018-2030 (USD MILLION)
  • TABLE 68. BRAZIL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 69. BRAZIL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. CANADA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 71. CANADA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 72. CANADA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LARGE MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 73. CANADA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 74. CANADA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 75. CANADA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 76. CANADA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRECLINICAL, 2018-2030 (USD MILLION)
  • TABLE 77. CANADA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 78. CANADA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. MEXICO HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 80. MEXICO HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 81. MEXICO HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LARGE MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 82. MEXICO HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 83. MEXICO HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 84. MEXICO HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 85. MEXICO HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRECLINICAL, 2018-2030 (USD MILLION)
  • TABLE 86. MEXICO HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 87. MEXICO HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 89. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 90. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LARGE MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 91. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 92. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 93. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 94. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRECLINICAL, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LARGE MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRECLINICAL, 2018-2030 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 108. AUSTRALIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 109. AUSTRALIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 110. AUSTRALIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LARGE MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 111. AUSTRALIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 112. AUSTRALIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 113. AUSTRALIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 114. AUSTRALIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRECLINICAL, 2018-2030 (USD MILLION)
  • TABLE 115. AUSTRALIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 116. AUSTRALIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. CHINA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 118. CHINA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 119. CHINA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LARGE MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 120. CHINA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 121. CHINA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 122. CHINA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 123. CHINA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRECLINICAL, 2018-2030 (USD MILLION)
  • TABLE 124. CHINA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 125. CHINA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. INDIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 127. INDIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 128. INDIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LARGE MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 129. INDIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 130. INDIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 131. INDIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 132. INDIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRECLINICAL, 2018-2030 (USD MILLION)
  • TABLE 133. INDIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 134. INDIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. INDONESIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 136. INDONESIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 137. INDONESIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LARGE MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 138. INDONESIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 139. INDONESIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 140. INDONESIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 141. INDONESIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRECLINICAL, 2018-2030 (USD MILLION)
  • TABLE 142. INDONESIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 143. INDONESIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. JAPAN HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 145. JAPAN HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 146. JAPAN HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LARGE MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 147. JAPAN HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 148. JAPAN HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 149. JAPAN HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 150. JAPAN HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRECLINICAL, 2018-2030 (USD MILLION)
  • TABLE 151. JAPAN HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 152. JAPAN HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 153. MALAYSIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 154. MALAYSIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 155. MALAYSIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LARGE MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 156. MALAYSIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 157. MALAYSIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 158. MALAYSIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 159. MALAYSIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRECLINICAL, 2018-2030 (USD MILLION)
  • TABLE 160. MALAYSIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 161. MALAYSIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 162. PHILIPPINES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 163. PHILIPPINES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 164. PHILIPPINES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LARGE MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 165. PHILIPPINES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 166. PHILIPPINES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 167. PHILIPPINES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 168. PHILIPPINES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRECLINICAL, 2018-2030 (USD MILLION)
  • TABLE 169. PHILIPPINES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 170. PHILIPPINES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 171. SINGAPORE HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 172. SINGAPORE HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 173. SINGAPORE HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LARGE MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 174. SINGAPORE HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 175. SINGAPORE HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 176. SINGAPORE HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 177. SINGAPORE HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRECLINICAL, 2018-2030 (USD MILLION)
  • TABLE 178. SINGAPORE HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 179. SINGAPORE HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 180. SOUTH KOREA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 181. SOUTH KOREA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 182. SOUTH KOREA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LARGE MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 183. SOUTH KOREA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 184. SOUTH KOREA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 185. SOUTH KOREA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 186. SOUTH KOREA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRECLINICAL, 2018-2030 (USD MILLION)
  • TABLE 187. SOUTH KOREA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 188. SOUTH KOREA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 189. TAIWAN HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 190. TAIWAN HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 191. TAIWAN HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LARGE MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 192. TAIWAN HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 193. TAIWAN HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 194. TAIWAN HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 195. TAIWAN HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRECLINICAL, 2018-2030 (USD MILLION)
  • TABLE 196. TAIWAN HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 197. TAIWAN HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 198. THAILAND HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 199. THAILAND HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 200. THAILAND HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LARGE MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 201. THAILAND HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 202. THAILAND HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 203. THAILAND HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 204. THAILAND HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRECLINICAL, 2018-2030 (USD MILLION)
  • TABLE 205. THAILAND HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 206. THAILAND HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 207. VIETNAM HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 208. VIETNAM HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 209. VIETNAM HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LARGE MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 210. VIETNAM HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 211. VIETNAM HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 212. VIETNAM HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 213. VIETNAM HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRECLINICAL, 2018-2030 (USD MILLION)
  • TABLE 214. VIETNAM HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 215. VIETNAM HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 217. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LARGE MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRECLINICAL, 2018-2030 (USD MILLION)
  • TABLE 223. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 226. DENMARK HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 227. DENMARK HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 228. DENMARK HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LARGE MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 229. DENMARK HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 230. DENMARK HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 231. DENMARK HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 232. DENMARK HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRECLINICAL, 2018-2030 (USD MILLION)
  • TABLE 233. DENMARK HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 234. DENMARK HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 235. EGYPT HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 236. EGYPT HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 237. EGYPT HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LARGE MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 238. EGYPT HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL MOLECULE, 2018-2030 (USD MILLION)
  • TABLE 239. E